Learn More
Medchemexpress LLC DMAPT (Dimethylamino parthenolide) | 791595-09-0 | 98.0% | 293.40 | 25 MG

Supplier: Medchemexpress LLC 25MGHY16172
DMAPT (Dimethylamino Parthenolide), an analogue of Parthenolide (PTL), is an oral active NF-κB inhibitor with potential anti-cancer and anti-metastatic effects. It has an LD50 of 1.7 μM for cell population in AML cells.
- Oral active NF-κB inhibitor.
- LD50 of 1.7 μM for cell population in AML cells.
- Potential anti-cancer and anti-metastatic effect.
- Decreased constitutive NF-κB binding activity and inhibits cell proliferation and viability of PC-3 and DU145 cells.
- Increases sensitivity of PC-3 tumor xenografts to X-rays in vivo.
- Slows normal tumor development in TRAMP mice.
- Reduces metastatic area in lung tissues of TRAMP mice.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.